Rheumatoid Arthritis Clinical Trials in Houston, Texas

9 studies are recruiting for rheumatoid arthritis in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

   Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by B cell hyperactivity. Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. The purpose of this study is to assess the pharmacokinetics, …

   Stage

   Phase 1

   Ages

   18 to 75

   Site

   Accurate Clinical Research - Houston /ID# 278382, Houston, Texas

   Locations

   15 in total

   Run by

   AbbVie

   See if you can join NCT07607964 on ClinicalTrials.gov

2. A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

   This study will assess the efficacy and safety of Afimkibart (also known as RO7790121) compared with placebo in participants with moderate to severe rheumatoid arthritis (RA) who have an inadequate response or intolerance to TNF and/or JAK inhibitors.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Accurate Clinical Management, Houston, Texas

   Locations

   65 in total

   Run by

   Hoffmann-La Roche

   See if you can join NCT07137598 on ClinicalTrials.gov

3. An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis

   The study will evaluate the long-term safety and efficacy of Afimkibart (also known as RO7790121) in participants with moderate to severe Rheumatoid Arthritis (RA) who have an inadequate response or intolerance to tumor necrosis factor (TNF) and/or Janus kinase (JAK) inhibitors, and who were previo…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Accurate Clinical Management LLC, Houston, Texas

   Locations

   12 in total

   Run by

   Hoffmann-La Roche

   See if you can join NCT07620392 on ClinicalTrials.gov

4. Phase 1b/2 Study of IV Sarilumab in Adult With RA

   This is a Phase 1/Phase 2 study with: * 5-arms design for Part A; * and a single arm for Part B. The purpose of this study is to measure PK parameters and safety with sarilumab intravenous (IV) with or without concomitant oral conventional synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) …

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Prolato Clinical Research Center- Site Number : 8400006, Houston, Texas

   Locations

   12 in total

   Run by

   Sanofi

   See if you can join NCT07704580 on ClinicalTrials.gov

5. A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

   Phase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Research Site, Houston, Texas

   Locations

   147 in total

   Run by

   AstraZeneca

   See if you can join NCT07276581 on ClinicalTrials.gov

6. A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

   Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. This study will evaluate the efficacy and safety of targeted therapies through a series of substudies for the treatment of moderately to severely active Rheumatoid Arthritis (RA…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Accurate Clinical Research - Houston /ID# 272271, Houston, Texas

   Locations

   96 in total

   Run by

   AbbVie

   See if you can join NCT06972446 on ClinicalTrials.gov

7. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

   This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from …

   Stage

   Phase 1

   Ages

   18 and older

   Site

   UT MD Anderson Cancer Center, Houston, Texas

   Locations

   52 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT03816345 on ClinicalTrials.gov

8. RA-PRO PRAGMATIC TRIAL

   The 2021 ACR RA treatment guideline, based on widely acknowledged low to moderate quality evidence, recommends switching to a non-tumor necrosis factor (TNFi) biologic (choose among existing medications, currently, rituximab, abatacept, tocilizumab, or sarilumab) or a targeted synthetic DMARD arm (…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Baylor University, Houston, Texas

   Locations

   49 in total

   Run by

   University of Alabama at Birmingham

   See if you can join NCT04692493 on ClinicalTrials.gov

9. Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

   This study learn how easily patients can use an educational tool that will be created for patients with melanoma and pre-existing autoimmune diseases who receive or will receive immune checkpoint inhibitor drugs. Patients will be asked their opinions about the design, accessibility, and content of …

   Stage

   Not phased

   Ages

   18 and older

   Site

   M D Anderson Cancer Center, Houston, Texas

   Run by

   M.D. Anderson Cancer Center

   See if you can join NCT04751396 on ClinicalTrials.gov